Baylor College of Medicine
Houston, TX
Overview:
This presentation will provide clinicians with a history and an overview of lipid lowering therapies from statin therapies to non-statin LDL lowering therapies including ezetimibe, PCSK9 inhibitors, inclisiran. We will also discuss triglyceride lowering therapies as well as therapies on horizon to lower lipoprotein (a). We will also discuss what does the future hold for lipid lowering therapies including gene editing and how those can be personalized.
Objectives:
At the conclusion of the activity a participant should be able to:
- Describe the role of lipid lowering therapies in atherosclerotic cardiovascular disease (ASCVD) risk reduction
- Effectively integrate the use of statin and non-statin lipid lowering therapies in their clinical practice
- Describe the role of emerging lipid lowering therapies in lowering ASCVD risk
Texas Heart Institute Grand Rounds is an esteemed tradition that attracts leading experts from around the world each year.
Series attendees include Cardiology Fellows and Faculty, members of the Departments of Internal Medicine and Cardiovascular Surgery, as well as visitors from other clinical and teaching institutions in the Texas Medical Center. We live broadcast Grand Rounds for online viewing on any desktop computer or mobile device.
Live Webcasting
Register for Livestream and Reminders (Required to receive link by email)
2022-23 Faculty Schedule
2022-23 Grand Rounds Event Calendar
Obtain CME Credit
Accreditation and Credit Designation
Texas Heart Institute is accredited by the Accreditation Council or Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Texas Heart Institute designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Visit THI CME Portal
Questions? Contact CME@texasheart.org
